Wang X, Wang C, Zong D, Zhu B, et al. First-line treatment with cadonilimab plus paclitaxel-platinum +/- bevacizumab for persistent, recurrent, or metastatic cervical cancer: a retrospective real-world study. Front Oncol 2025;15:1634779.
PMID: 40936700